Lundin M - Search Results

1

Deep learning for detecting tumour-infiltrating lymphocytes in testicular germ cell tumours.

Linder N, Taylor JC, Colling R, Pell R, Alveyn E, Joseph J, Protheroe A, Lundin M, Lundin J, Verrill C. Linder N, et al. Among authors: lundin j, lundin m. J Clin Pathol. 2019 Feb;72(2):157-164. doi: 10.1136/jclinpath-2018-205328. Epub 2018 Dec 5. J Clin Pathol. 2019. PMID: 30518631

2

Sialyl Tn is a frequently expressed antigen in colorectal cancer: No correlation with patient prognosis.

Lundin M, Nordling S, Roberts PJ, Lundin J, Carpelan-Holmström M, von Boguslawsky K, Haglund C. Lundin M, et al. Among authors: lundin j. Oncology. 1999 Jul;57(1):70-6. doi: 10.1159/000012003. Oncology. 1999. PMID: 10394128

3

Artificial neural networks applied to survival prediction in breast cancer.

Lundin M, Lundin J, Burke HB, Toikkanen S, Pylkkänen L, Joensuu H. Lundin M, et al. Among authors: lundin j. Oncology. 1999 Nov;57(4):281-6. doi: 10.1159/000012061. Oncology. 1999. PMID: 10575312

4

Omission of histologic grading from clinical decision making may result in overuse of adjuvant therapies in breast cancer: results from a nationwide study.

Lundin J, Lundin M, Holli K, Kataja V, Elomaa L, Pylkkänen L, Turpeenniemi-Hujanen T, Joensuu H. Lundin J, et al. Among authors: lundin m. J Clin Oncol. 2001 Jan 1;19(1):28-36. doi: 10.1200/JCO.2001.19.1.28. J Clin Oncol. 2001. PMID: 11134192

5

Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer.

Wiksten JP, Lundin J, Nordling S, Lundin M, Kokkola A, von Boguslawski K, Haglund C. Wiksten JP, et al. Among authors: lundin j, lundin m. Int J Cancer. 2001 Jan 20;95(1):1-6. doi: 10.1002/1097-0215(20010120)95:1<1::aid-ijc1000>3.0.co;2-5. Int J Cancer. 2001. PMID: 11241302

6

Tissue expression of human chorionic gonadotropin beta predicts outcome in colorectal cancer: a comparison with serum expression.

Lundin M, Nordling S, Lundin J, Alfthan H, Stenman UH, Haglund C. Lundin M, et al. Among authors: lundin j. Int J Cancer. 2001 Jan 20;95(1):18-22. doi: 10.1002/1097-0215(20010120)95:1<18::aid-ijc1003>3.0.co;2-5. Int J Cancer. 2001. PMID: 11241305

7

Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.

Ristimäki A, Sivula A, Lundin J, Lundin M, Salminen T, Haglund C, Joensuu H, Isola J. Ristimäki A, et al. Among authors: lundin j, lundin m. Cancer Res. 2002 Feb 1;62(3):632-5. Cancer Res. 2002. PMID: 11830510

8

A web-based system for individualised survival estimation in breast cancer.

Lundin J, Lundin M, Isola J, Joensuu H. Lundin J, et al. Among authors: lundin m. BMJ. 2003 Jan 4;326(7379):29. doi: 10.1136/bmj.326.7379.29. BMJ. 2003. PMID: 12511459 Free PMC article. No abstract available.

9

Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study.

Joensuu H, Isola J, Lundin M, Salminen T, Holli K, Kataja V, Pylkkänen L, Turpeenniemi-Hujanen T, von Smitten K, Lundin J. Joensuu H, et al. Among authors: lundin j, lundin m. Clin Cancer Res. 2003 Mar;9(3):923-30. Clin Cancer Res. 2003. PMID: 12631589

10

Tenascin-C expression correlates with prognosis in gastric cancer.

Wiksten JP, Lundin J, Nordling S, Lundin M, Kokkola A, von Boguslawski K, Haglund C. Wiksten JP, et al. Among authors: lundin j, lundin m. Oncology. 2003;64(3):245-50. doi: 10.1159/000069305. Oncology. 2003. PMID: 12697965

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters